The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Aptose Biosciences; Cellectis; CohBar; CytomX Therapeutics; FibroGen; Global Blood Therapeutics; Guardant Health; Halozyme; Portola Pharmaceuticals; Sangamo Therapeutics; TG Therapeutics; Zymeworks
Honoraria - Gilead Sciences; Guardant Health; Natera
Speakers' Bureau - Guardant Health
Research Funding - Guardant Health (Inst); Mirati Therapeutics (Inst)
Travel, Accommodations, Expenses - Mirati Therapeutics
Phase III trial of sitravatinib plus nivolumab vs. docetaxel for treatment of NSCLC after platinum-based chemotherapy and immunotherapy (SAPPHIRE).
 
Ivor John Percent
No Relationships to Disclose
 
Craig H. Reynolds
Leadership - American Oncology Network
Stock and Other Ownership Interests - American Oncology Network; Gilead Sciences
Honoraria - Bristol-Myers Squibb; Celgene; Genentech; Lilly; Merck Sharp & Dohme
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Lilly
Speakers' Bureau - Celgene; Genentech; Merck Sharp & Dohme
 
Kartik Konduri
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim France; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Takeda
 
Matthew Thomas Whitehurst
Employment - Hematology Oncology Associates of Fredericksburg
Honoraria - Hematology Oncology Associates of Fredericksburg
 
Emmanuel A. Nidhiry
Employment - Commonwealth Cancer Center
Leadership - Commonwealth Cancer Center
Stock and Other Ownership Interests - Commonwealth Cancer Center
 
Ronald H. Yanagihara
Stock and Other Ownership Interests - Abbvie/Pharmacyclics; Amgen; AstraZeneca; Biogen; Bristol-Myers Squibb; Celgene; Editas Medicine; Genomic Health; Novartis
Honoraria - AstraZeneca
Research Funding - Genentech/Roche (Inst); Mirati Therapeutics (Inst)
 
Misako Nagasaka
Consulting or Advisory Role - AstraZeneca
Research Funding - Tempus
 
Marshall T Schreeder
No Relationships to Disclose
 
James Uyeki
No Relationships to Disclose
 
Georges Azzi
No Relationships to Disclose
 
Krishna Kishore Pachipala
Honoraria - Axess Oncology
Consulting or Advisory Role - Axess Oncology
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst)
 
Jason C. Comer
No Relationships to Disclose
 
Rachel E. Lerner
No Relationships to Disclose
 
Ticiana Leal
Consulting or Advisory Role - Abbvie; AstraZeneca; AstraZeneca; Bayer; BeyondSpring Pharmaceuticals; Bristol-Myers Squibb; Bristol-Myers Squibb; Genentech; Genentech; InvisionFirst Lung; Merck; Merck; Novocure; Takeda; Takeda
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Genentech; Merck; Mirati Therapeutics; Mirati Therapeutics; Mirati Therapeutics; Takeda; Takeda
 
Delia Alvarez
Employment - Mirati Therapeutics
Stock and Other Ownership Interests - Mirati Therapeutics
 
Saskia T.C. Neuteboom
Employment - Mirati Therapeutics
Stock and Other Ownership Interests - Mirati Therapeutics
 
Natasha Reddinger
Employment - Mirati Therapeutics
Stock and Other Ownership Interests - Mirati Therapeutics
 
xiaohong yan
Employment - Mirati Therapeutics
Stock and Other Ownership Interests - Mirati Therapeutics
Travel, Accommodations, Expenses - Mirati Therapeutics
 
Ronald L. Shazer
Employment - Denovo Biopharma; Inspyr Therapeutics; Mirati Therapeutics
Leadership - Denovo Biopharma; Inspyr Therapeutics
Stock and Other Ownership Interests - Bristol-Myers Squibb; Mirati Therapeutics; Pfizer
Consulting or Advisory Role - eFFECTOR Therapeutics
 
David Michael Waterhouse
Consulting or Advisory Role - Abbvie; Amgen; AZTherapies; Bristol-Myers Squibb; Celgene; CTI; Janssen Oncology; McGivney Global Advisors
Speakers' Bureau - Bristol-Myers Squibb; Janssen Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb